Financial statements Pharmapolis Jaszczuk
Balance sheet data of PHARMAPOLIS JASZCZUK
|
Year
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
|---|---|---|---|---|---|---|
| Total assets | 1 601 280,08 | 1 812 591,92 | 1 841 042,79 | 4 663 962,51 | 5 079 504,89 | 6 876 839,33 |
| A. Fixed assets | 137 735,47 | 108 023,41 | 68 311,35 | 293 599,29 | 203 887,23 | 135 000,00 |
| B. Current assets | 1 463 544,61 | 1 704 568,51 | 1 772 731,44 | 4 370 363,22 | 4 875 617,66 | 6 741 839,33 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | - |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | - |
| Total liabilities | 1 601 280,08 | 1 812 591,92 | 1 841 042,79 | 4 663 962,51 | 5 079 504,89 | 6 876 839,33 |
| A. Equity | -1 105 323,31 | -1 845 119,15 | -2 534 236,79 | 135 216,47 | 70 871,25 | 1 550 927,53 |
| B. Liabilities and provisions for liabilities | 2 706 603,39 | 3 657 711,07 | 4 375 279,58 | 4 528 746,04 | 5 008 633,64 | 5 325 911,80 |
| I. Long-term liabilities | 0,00 | 2 909 175,00 | 3 422 750,76 | 2 400 000,00 | 2 600 000,00 | 2 370 000,00 |
| II. Short-term liabilities | 2 705 328,89 | 748 536,07 | 952 528,82 | 2 128 746,04 | 2 408 606,42 | 2 955 911,80 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.